To determine the incidence of angioedema associated with ACE inhibitors versus placebo in the treatment of primary hypertension.
This is a protocol.
Angiotensin converting enzyme inhibitor induced angioedema in patients with primary hypertension
You may also be interested in:
- Angiotensin converting enzyme (ACE) gene polymorphism (ACEI/D) in hypertensive adults with ACE inhibitor-induced cough
- Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension
- Time course for blood pressure lowering of angiotensin-converting-enzyme inhibitors
- Renin inhibitors versus angiotensin converting enzyme (ACE) inhibitors for primary hypertension
- Blood pressure lowering efficacy of drugs inhibiting the renin-angiotensin system as second-line therapy for primary hypertension
Health topics: